The following warning is currently published on the DEA website:
 
The Drug Enforcement Administration is warning the public including the DEA registrant community to include practitioners and pharmacies about criminals posing as DEA Special Agents, DEA Investigators or other law enforcement personnel as part of an international extortion scheme.

The following warning is currently published on the DEA website:
 
The Drug Enforcement Administration is warning the public including the DEA registrant community to include practitioners and pharmacies about criminals posing as DEA Special Agents, DEA Investigators or other law enforcement personnel as part of an international extortion scheme.
The criminals call the victims (who in most cases previously purchased drugs over the internet or by telephone) and identify themselves as DEA agents or law enforcement officials from other agencies. The impersonators inform their victims that purchasing drugs over the internet or by telephone is illegal, and that enforcement action will be taken against them unless they pay a fine. In most cases, the impersonators instruct their victims to pay the "fine" via wire transfer to a designated location, usually overseas. If victims refuse to send money, the impersonators often threaten to arrest them or search their property. Some victims who purchased their drugs using a credit card also reported fraudulent use of their credit cards. Another scheme involves criminals contacting doctors and pharmacists and stating that they are the subject of an investigation and demanding money to clear up the matter.

Anyone receiving a telephone call from a person purporting to be a DEA special agent, DEA Investigator, or other law enforcement official seeking money should refuse the demand and report the threat using the online form below.

https://www.deadiversion.usdoj.gov/pubs/pressreleases/extortion_scam.htm

Life-threatening breathing difficulties can occur in patients who use gabapentin or pregabalin with opioids or other drugs that depress the central nervous system, as well as those with underlying respiratory impairment and the elderly, the US Food and Drug Administration (FDA) warned in a drug safety communication issued today.
 
To read more, please click here: https://www.rxlist.com/script/main/art.asp?articlekey=226865
 
Source: www.pharmacyexam.com

Life-threatening breathing difficulties can occur in patients who use gabapentin or pregabalin with opioids or other drugs that depress the central nervous system, as well as those with underlying respiratory impairment and the elderly, the US Food and Drug Administration (FDA) warned in a drug safety communication issued today.
 
To read more, please click here: https://www.rxlist.com/script/main/art.asp?articlekey=226865
 
Source: www.pharmacyexam.com

Negative childhood events and family history could increase risk.
 
Most of us experience anxiety at some point in our lives. You might feel anxious when taking a test, crossing a busy street, or making an important life decision.
 
But for people with an anxiety disorder, these feelings usually last longer and are more intense. They often worsen over time and interfere with everyday life.
 
Anxiety disorders are the most common form of mental illness and affect more than 25 million Americans. There are a variety of anxiety disorders, though many share similar symptoms and methods of treatment.
 
To read more, please click here: https://magazine.medlineplus.gov/article/anxiety-what-you-need-to-know
 
Source: www.pharmacyexam.com

Negative childhood events and family history could increase risk.
 
Most of us experience anxiety at some point in our lives. You might feel anxious when taking a test, crossing a busy street, or making an important life decision.
 
But for people with an anxiety disorder, these feelings usually last longer and are more intense. They often worsen over time and interfere with everyday life.
 
Anxiety disorders are the most common form of mental illness and affect more than 25 million Americans. There are a variety of anxiety disorders, though many share similar symptoms and methods of treatment.
 
To read more, please click here: https://magazine.medlineplus.gov/article/anxiety-what-you-need-to-know
 
Source: www.pharmacyexam.com

Hypochromic microcytic anemia with iron overload is a condition that impairs the normal transport of iron in cells. Iron is an essential component of hemoglobin, which is the substance that red blood cells use to carry oxygen to cells and tissues throughout the body. 

Hypochromic microcytic anemia with iron overload is a condition that impairs the normal transport of iron in cells. Iron is an essential component of hemoglobin, which is the substance that red blood cells use to carry oxygen to cells and tissues throughout the body. In this condition, red blood cells cannot access iron in the blood, so there is a decrease of red blood cell production (anemia) that is apparent at birth. The red blood cells that are produced are abnormally small (microcytic) and pale (hypochromic). Hypochromic microcytic anemia with iron overload can lead to pale skin (pallor), tiredness (fatigue), and slow growth.
 
In hypochromic microcytic anemia with iron overload, the iron that is not used by red blood cells accumulates in the liver, which can impair its function over time. The liver problems typically become apparent in adolescence or early adulthood.
 
For more information, click here: https://ghr.nlm.nih.gov/condition/hypochromic-microcytic-anemia-with-iron-overload

Prescription drug samples may only be distributed to licensed practitioners or to the retail pharmacies, the pharmacies of hospitals or other health care entities upon the written request of a licensed practitioner.
 
a. True
b. False

Prescription drug samples may only be distributed to licensed practitioners or to the retail pharmacies, the pharmacies of hospitals or other health care entities upon the written request of a licensed practitioner.
 
a. True
b. False

Answer: (b) False, [21 CFR 203.3 and Section 503(d) of the Act].
 
Under section 503(d) of the FFDCA, prescription drug samples may only be distributed to licensed practitioners or to the pharmacies of hospitals or other health care entities upon the written request of a licensed practitioner.
 
A “health care entity” means any person that provides diagnostic, medical, surgical, or dental treatment, or chronic or rehabilitative care, but does not include any retail pharmacy (21 CFR 203.3(q)).
 
A health care entity cannot simultaneously also be a retail pharmacy.
 
If a pharmacy of a health care entity operates as part of the health care entity, it is eligible to receive prescription drug samples from a manufacturer or authorized distributor of record, if the drug samples are obtained pursuant to a written, signed request of a licensed practitioner affiliated with the health care entity.
 
“Affiliation” is interpreted to mean that the requesting practitioner sees patients at the health care entity. A retail pharmacy that has no relationship to a health care entity is not permitted to receive prescription drug samples (21 CFR 203.3 and Section 503(d) of the Act).

We have recently created new product for Federal Pharmacy Law Disc 3.

Below is the link for product information....

We have recently created new product for Federal Pharmacy Law Disc 3.

Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/189/federal-pharmacy-law-test---3.cfm

Pharmacy Exam

(a). A purchaser must make a copy of the original DEA Form 222 for its records and then submit the original to the supplier. The copy retained by the purchaser may be in paper or electronic form.

(b). A supplier may fill the order, if possible and if the supplier desires to do so, and must record on the original DEA Form 222 its DEA registration number and the number of commercial or bulk containers furnished on each item and the date on which the containers are shipped to the purchaser......

(a). A purchaser must make a copy of the original DEA Form 222 for its records and then submit the original to the supplier. The copy retained by the purchaser may be in paper or electronic form.

(b). A supplier may fill the order, if possible and if the supplier desires to do so, and must record on the original DEA Form 222 its DEA registration number and the number of commercial or bulk containers furnished on each item and the date on which the containers are shipped to the purchaser.

If an order cannot be filled in its entirety, it may be filled in part and the balance supplied by additional shipments within 60 days following the date of the DEA Form 222. No DEA Form 222 is valid more than 60 days after its execution by the purchaser, except as specified in paragraph (f) of this section.

(c). The controlled substances must be shipped only to the purchaser and the location printed by the Administration on the DEA Form 222, except as specified in paragraph (f) of this section.

(d). The supplier must retain the original DEA Form 222 for the supplier's files in accordance with §1305.17(c). Any supplier who is not required to report acquisition/disposition transactions to the Automation of Reports and Consolidated Orders System (ARCOS) under §1304.33(c) (such as a practitioner) must make and submit a copy of the original DEA Form 222 to DEA, either by mail to the Registration Section, or by email to [email protected].

The copy must be forwarded at the close of the month (not the close of next month) during which the order is filled. If an order is filled by partial shipments, the copy must be forwarded at the close of the month during which the final shipment is made or the 60-day validity period expires.

(e). The purchaser must record on its copy of the DEA Form 222 the number of commercial or bulk containers furnished on each item and the dates on which the containers are received by the purchaser.

(f). DEA Forms 222 submitted by registered procurement officers of the Defense Supply Center of the Defense Logistics Agency for delivery to armed services establishments within the United States may be shipped to locations other than the location printed on the DEA Form 222, and in partial shipments at different times not to exceed six months from the date of the order, as designated by the procurement officer when submitting the order.

PharmacyExam is proud to announce it first mobile application for studying NAPLEX through Naplex Audio Books and Naplex Flash Cards. Please download and review the app free by clicking appropriate below link.

For Google Play Store

https://play.google.com/store/apps/details?id=com.rxexam.naplex

For Itune App Store

https://itunes.apple.com/us/app/rxexam/id1448199697?ls=1&mt=8

We hope you like it.

Pharmacy Exam

PharmacyExam is proud to announce it first mobile application for studying NAPLEX through Naplex Audio Books and Naplex Flash Cards. Please download and review the app free by clicking appropriate below link.

For Google Play Store

https://play.google.com/store/apps/details?id=com.rxexam.naplex

For Itune App Store

https://itunes.apple.com/us/app/rxexam/id1448199697?ls=1&mt=8

We hope you like it.

Pharmacy Exam

We have recently created new product for letting students familiar with Biostatistics.

Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/185/naplex---biostatistics.cfm

You can also view sample questions related to this product by visiting following link:

https://www.pharmacyexam.com/images/pdf/Biostatistics_Sample_Questions.pdf

Pharmacy Exam

We have recently created new product for letting students familiar with Biostatistics.

Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/185/naplex---biostatistics.cfm

You can also view sample questions related to this product by visiting following link:

https://www.pharmacyexam.com/images/pdf/Biostatistics_Sample_Questions.pdf

Pharmacy Exam

We have recently created new product for letting students familiar with sterile compounding and hazardous drugs. Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/183/sterile-compounding--hazardous-drugs.cfm

You can also view sample questions related to this product by visiting following link:

https://www.pharmacyexam.com/index.cfm?fuseaction=category.display&category_id=184

Pharmacy Exam

We have recently created new product for letting students familiar with sterile compounding and hazardous drugs. Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/183/sterile-compounding--hazardous-drugs.cfm

You can also view sample questions related to this product by visiting following link:

https://www.pharmacyexam.com/index.cfm?fuseaction=category.display&category_id=184

Pharmacy Exam